News

An experimental drug may offer a safe and effective treatment option for metabolic dysfunction-associated steatohepatitis ...
Co ( (HK:2196)). Shanghai Fosun Pharmaceutical announced that its subsidiary, Jinzhou Avanc Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for the ...
On the FDA’s docket for the back half of September is Merck’s proposed subcutaneous formulation of its blockbuster cancer drug Keytruda.